The pacemaker has no single inventor. Its development stretches across decades and continents, with credit belonging to a loose chain of physicians and engineers who each solved a different piece of the puzzle. The earliest functional device was built by an Australian physician named Mark Lidwell around 1929, though the American Albert Hyman is often credited with coining the term “artificial pacemaker” a few years later. From those crude external machines to the tiny leadless capsules implanted today, the pacemaker’s story is one of incremental breakthroughs rather than a lone eureka moment.
The Contested Origins
The idea of using electricity to stimulate the heart predates the pacemaker by well over a century. Experiments in the late 1700s demonstrated that electrical current could make muscle tissue contract, and by the 1800s researchers were attempting to revive stopped hearts with jolts of current. But turning that concept into a portable, repeatable medical device took until the twentieth century.
The first person to build something recognizable as a cardiac pacemaker and actually use it on a patient was Mark Lidwell, an anesthesiologist in Sydney. In or before 1929, Lidwell used a device he had constructed to deliver electrical impulses to the heart of a stillborn infant, successfully resuscitating it. His work was presented at a medical conference but received little attention, partly because Lidwell himself was reluctant to publicize it amid ethical concerns about artificially restarting a heart.1PubMed. The Australian history of cardiac pacing: memories from a bygone era
A few years later in 1932, Albert Hyman, a cardiologist in New York, independently built his own device, which he called an “artificial pacemaker.” Hyman’s machine was hand-cranked and delivered electrical pulses through a needle electrode inserted into the heart. He tested it on animals and reportedly on some patients, though published documentation of successful human use is thin. Hyman himself acknowledged Lidwell’s earlier achievement.1PubMed. The Australian history of cardiac pacing: memories from a bygone era Neither device gained traction in clinical practice, but they proved the core concept: a machine could take over the job of the heart’s natural electrical system.
From Hypothermia Experiments to External Pacing
The pacemaker’s next major leap came from an unexpected direction. In 1949, the Canadian surgeon Wilfred Bigelow was studying how to perform cardiac surgery on dogs under deep hypothermia, which slowed or stopped the heart. During one of these experiments, Bigelow discovered he could restart a stopped dog heart by stimulating it with a catheter threaded through a vein. He recognized the therapeutic potential immediately and teamed up with John Hopps, an electrical engineer at the National Research Council of Canada, and fellow physician John Callaghan. Together they developed an external pacemaker that could deliver controlled electrical pulses to the heart through a transvenous catheter.2Heart, Vessels and Transplantation. Evolution of cardiac pacemakers: a journey from Galvanic experiments to leadless pacemakers
The Hopps-Bigelow-Callaghan device was far too large to implant. It was roughly the size of a small suitcase and ran on wall power. But it represented a critical engineering step forward: a machine that could reliably pace the heart at a set rhythm using electronics rather than hand cranks or crude batteries. Around the same time, the American cardiologist Paul Zoll demonstrated in 1952 that he could pace a human heart using electrodes placed on the chest wall rather than threaded into the body. External pacing using skin-surface electrodes became an established emergency tool over the following decades, though it came with significant drawbacks, including pain for the conscious patient and the risk of skin burns at high current densities.3PubMed Central. Third-degree burns caused by transcutaneous pacing for third-degree heart block
The Jump to Implantable Devices
The real transformation came in the late 1950s, when two teams working independently on different continents managed to shrink the pacemaker enough to put it inside the body. In Sweden, physician Åke Senning and engineer Rune Elmqvist developed a small pulse generator encased in epoxy resin. On October 8, 1958, Senning implanted their device into Arne Larsson, a 43-year-old engineer suffering from complete heart block that caused him to lose consciousness dozens of times a day. The first unit failed within hours and had to be replaced the next day with a second, which lasted a few weeks. Larsson ultimately received 26 pacemaker systems over his lifetime and lived to the age of 86, outliving both the surgeon and the engineer who built his first device.
Meanwhile, in the United States, Wilson Greatbatch had stumbled upon the pacemaker concept almost by accident. While building an oscillator circuit intended to record heart rhythms, he installed the wrong resistor and noticed the device produced rhythmic electrical pulses that mimicked a heartbeat. Greatbatch refined this into an implantable unit, and in 1960, surgeon William Chardack performed the first successful implantation of Greatbatch’s device in a human patient in Buffalo, New York.
What is striking is that both the Swedish and American teams independently arrived at nearly identical circuit designs. Both Elmqvist and Greatbatch used a transistorized blocking oscillator as the heart of their device, taking advantage of the recently available silicon transistor, which was small enough and reliable enough to make implantation feasible.4PubMed. Pioneering Rhythm Management: A Design Analysis of the Earliest Battery-Powered Implantable Pacemakers Neither team knew about the other’s work. The transistor, barely a decade old at the time, was the enabling technology. Without it, the circuitry simply could not have been made small or energy-efficient enough to fit inside a human body.
How the Early Pacemakers Actually Worked
At their core, those first implantable pacemakers were simple. A battery provided power. A transistorized oscillator circuit generated a brief electrical pulse at a fixed interval, and a wire (the “lead”) delivered that pulse to the heart muscle. The pulse triggered a contraction, forcing the heart to beat at whatever rate the device was set to. Early devices fired at around 70 to 80 pulses per minute, mimicking a normal resting heart rate.
These were “fixed-rate” or “asynchronous” pacemakers, meaning they fired their electrical impulses on a rigid schedule regardless of what the heart was doing on its own. If the patient’s heart happened to produce a natural beat at the same moment the pacemaker fired, the two signals would compete. This competition between natural and artificial impulses could cause inefficient contractions and, in rare cases, trigger dangerous heart rhythms.5Journal of the American College of Cardiology. Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series
Battery life was another persistent headache. The earliest implantable pacemakers used zinc-mercury batteries that lasted only a year or two, requiring repeated surgeries to swap them out. The introduction of lithium-iodide batteries in the 1970s was a quiet revolution: these cells could power a pacemaker for a decade or more and were far more predictable in how they discharged, giving doctors reliable warning before replacement was needed.
Demand Pacing Changed Everything
The fix for the competition problem came with “demand” pacing, developed through the 1960s. Instead of firing blindly on a timer, demand pacemakers included a sensing circuit that could detect the heart’s own electrical activity. When the device sensed a natural heartbeat, it held off on delivering a pulse. When the heart failed to beat within a set time window, the pacemaker stepped in. This “sense-and-pace” approach eliminated the clash between natural and artificial rhythms and made pacemakers far safer for the majority of patients whose hearts still beat on their own some of the time.5Journal of the American College of Cardiology. Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series
Demand pacing also extended battery life, since the device only generated pulses when needed. For a patient whose heart merely slowed down occasionally rather than stopping altogether, the pacemaker might fire only a small fraction of the time, conserving energy dramatically compared to a fixed-rate device firing nonstop.
Teaching Pacemakers to Speed Up and Slow Down
Fixed-rate and demand pacemakers both shared a limitation: they kept the heart at a single programmed rate. That works fine when you are sitting in a chair, but your heart needs to beat faster when you climb stairs or go for a walk. A healthy heart speeds up because the brain sends signals through the autonomic nervous system; a pacemaker-dependent heart cannot respond to those signals if the device only knows one speed.
Rate-responsive pacing, introduced in the 1980s, solved this by adding sensors that estimate the patient’s physical activity level. The most common approach uses a built-in accelerometer that detects body movement: when you start walking, the vibrations increase, and the pacemaker speeds up the heart accordingly. Other designs sense changes in breathing rate via chest impedance, or monitor the interval between specific points in the heart’s electrical cycle to gauge metabolic demand.6PubMed Central. Rate-Responsive Cardiac Pacing: Technological Solutions and Their Applications
Around the same time, dual-chamber pacemakers appeared. Earlier devices typically paced only the ventricle, the heart’s main pumping chamber. Dual-chamber systems added a second lead in the atrium, allowing the pacemaker to coordinate the timing between the upper and lower chambers the way a healthy heart does naturally. The first dual-chamber rate-responsive pacemaker was implanted in June 1986, combining both innovations in a single device for patients with disease affecting multiple parts of the heart’s conduction system.7Journal of Electrophysiology. Clinical Experience with Dual‐Chamber Rate Responsive Pacemakers
When the Leads Became the Weak Link
As the electronics inside pacemakers grew more reliable, the leads connecting the device to the heart emerged as the most failure-prone component. A pacemaker lead is a thin, flexible wire that snakes through a vein into the heart, and it endures constant motion from every heartbeat, every breath, and every movement of the arm and shoulder. Over years, that mechanical stress can cause the wire to fracture.
Lead fractures occur at a rate of roughly 0.1 to 4.2 percent per patient per year. The most vulnerable spot is near the point where the lead enters the vein, accounting for about 40 percent of fractures, often because the wire gets pinched between the collarbone and the first rib. Another 28 percent break along the segment between the vein entry point and the pacemaker generator, and about 23 percent fracture close to the generator itself. Physical exertion is an uncommon but recognized trigger.8PubMed Central. A Rare Case of Complete Fragmentation of Pacemaker Lead after a High-Velocity Theme Park Ride
A fractured lead can cause the pacemaker to lose contact with the heart, meaning pacing pulses go undelivered. In some cases the break is intermittent, producing erratic pacing that is difficult to diagnose. Extracting an old, embedded lead from inside a vein is a delicate procedure with its own risks, as scar tissue grows around the wire over time. This extraction challenge means that failed leads are sometimes simply abandoned in place and a new one threaded alongside, which creates its own long-term problems with vein crowding.
Going Leadless
The vulnerabilities of transvenous leads motivated one of the biggest recent shifts in pacemaker design: eliminating the lead entirely. Leadless pacemakers are self-contained capsules, roughly the size of a large vitamin pill, that are threaded through a catheter in the leg vein and anchored directly into the wall of the right ventricle. The battery, circuitry, and electrode are all housed in the same tiny device, removing the lead-related complications that had plagued conventional systems for decades.9PubMed Central. Leadless Pacemakers: Current Achievements and Future Perspectives
These devices became possible only through advances in battery chemistry and extreme miniaturization of electronic components. Current leadless pacemakers can sense the heart’s rhythm, pace on demand, and even respond to activity levels using built-in accelerometers that detect both body movement and the mechanical wave of each heartbeat.6PubMed Central. Rate-Responsive Cardiac Pacing: Technological Solutions and Their Applications The main limitation so far has been that early leadless devices could only pace the ventricle, not the atrium. Newer generations are working to close that gap with systems that communicate wirelessly between chambers.
Pacemakers and MRI Machines
For decades, having a pacemaker meant you could not get an MRI scan, which was a serious practical problem given how commonly MRI is used in modern medicine. The strong magnetic fields and radiofrequency energy generated by an MRI scanner can interfere with a pacemaker’s electronics, potentially causing it to pace erratically, heat the lead tips, or reset to a backup mode. For patients who needed both a pacemaker and regular MRI monitoring of another condition, this was a frustrating gap.
MRI-conditional pacemakers, first introduced in 2008, were specifically engineered to minimize these interactions. Modifications to both the generator and the leads reduce the risk of heating and electromagnetic interference, making it safe for patients to undergo MRI scans as long as specific conditions are met, such as scanning within approved body regions and field strengths.10PubMed Central. MRI-conditional pacemakers: current perspectives Today most newly implanted pacemakers carry MRI-conditional labeling, though patients with older systems still face restrictions.
How Pacemakers Reshaped Survival
Before pacemakers, complete heart block was frequently a death sentence. The heart’s ventricles might beat on their own at a dangerously slow rate, leaving patients dizzy, fainting, and unable to function. Many died from the condition or its complications. Early studies of pacemaker recipients showed that even among the oldest patients, implantation significantly prolonged life and improved its quality, with low surgical risk.11PubMed. Long-term survival of elderly patients after pacemaker implatation
Today, pacemaker implantation is one of the most common cardiac procedures performed worldwide, with well over a million devices implanted each year globally. The surgery itself typically takes about an hour, is done under local anesthesia with mild sedation, and most patients go home the same day or the next morning. Battery replacement every 7 to 15 years is the main recurring intervention, and it is considerably simpler than the original implant because the leads are already in place.
The gap between Lidwell’s improvised machine in a Sydney hospital room and today’s wireless capsule pacemakers is enormous in engineering terms, but the fundamental idea has not changed. The heart needs an electrical impulse to contract. When the body’s own wiring fails to deliver one on time, a small device steps in and provides it. Every generation of pacemaker has simply found a better, smaller, safer way to do that single job.